Total Payments
$9,892
2024 Payments
$262.45
Companies
9
Transactions
20
Medicare Patients
1,958
Medicare Billing
$86,264
Payment Breakdown by Category
Consulting$7,140 (72.2%)
Other$1,500 (15.2%)
Travel$817.05 (8.3%)
Food & Beverage$435.02 (4.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $7,140 | 4 | 72.2% |
| Compensation for serving as faculty or as a speaker for a medical education program | $1,500 | 1 | 15.2% |
| Travel and Lodging | $817.05 | 2 | 8.3% |
| Food and Beverage | $435.02 | 13 | 4.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. | $7,140 | 4 | $0 (2023) |
| Synthes GmbH | $2,317 | 3 | $0 (2023) |
| Genentech USA, Inc. | $131.75 | 1 | $0 (2022) |
| Tarsus Pharmaceuticals, Inc. | $121.49 | 4 | $0 (2024) |
| Amgen Inc. | $95.77 | 4 | $0 (2024) |
| ABBVIE INC. | $25.92 | 1 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $25.22 | 1 | $0 (2023) |
| Bausch & Lomb Americas Inc. | $19.27 | 1 | $0 (2024) |
| Alcon Laboratories Inc | $15.60 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $262.45 | 10 | Tarsus Pharmaceuticals, Inc. ($121.49) |
| 2023 | $9,482 | 8 | Regeneron Pharmaceuticals, Inc. ($7,140) |
| 2022 | $131.75 | 1 | Genentech USA, Inc. ($131.75) |
| 2017 | $15.60 | 1 | Alcon Laboratories Inc ($15.60) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $29.77 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 12/19/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/13/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug), MIEBO, LOTEMAX SM | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: Ophthalmology | ||||||
| 11/07/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $34.54 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 10/31/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $25.92 | General |
| Category: EYE CARE | ||||||
| 10/24/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $38.00 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 06/11/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/14/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $26.09 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/02/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 04/04/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/16/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.22 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/05/2023 | Synthes GmbH | — | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,500.00 | General |
| 03/05/2023 | Synthes GmbH | — | Travel and Lodging | In-kind items and services | $540.79 | General |
| 03/05/2023 | Synthes GmbH | — | Travel and Lodging | In-kind items and services | $276.26 | General |
| 02/10/2023 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Consulting Fee | Cash or cash equivalent | $3,825.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/10/2023 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Consulting Fee | Cash or cash equivalent | $2,805.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/10/2023 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Consulting Fee | Cash or cash equivalent | $255.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/10/2023 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Consulting Fee | Cash or cash equivalent | $255.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/08/2022 | Genentech USA, Inc. | Erivedge (Biological) | Food and Beverage | In-kind items and services | $131.75 | General |
| Category: BioOncology | ||||||
| 02/15/2017 | Alcon Laboratories Inc | DAILIES (Device) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 416 | 542 | $85,112 | $17,258 |
| 2022 | 8 | 500 | 618 | $101,985 | $20,706 |
| 2021 | 10 | 533 | 676 | $122,456 | $25,406 |
| 2020 | 7 | 509 | 606 | $97,143 | $22,895 |
Total Patients
1,958
Total Services
2,442
Medicare Billing
$86,264
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 103 | 168 | $26,390 | $4,607 | 17.5% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 72 | 81 | $11,143 | $3,160 | 28.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 55 | 94 | $14,512 | $2,713 | 18.7% |
| 92002 | New patient problem focused exam of visual system | Office | 2023 | 61 | 61 | $10,349 | $2,013 | 19.5% |
| 92012 | Established patient problem focused exam of visual system | Facility | 2023 | 51 | 53 | $7,259 | $1,883 | 25.9% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 26 | 26 | $5,486 | $1,367 | 24.9% |
| 68801 | Dilation of tear drainage opening | Office | 2023 | 15 | 18 | $7,308 | $1,030 | 14.1% |
| 92081 | Exam of visual field with limited testing | Facility | 2023 | 15 | 21 | $1,365 | $251.60 | 18.4% |
| 92081 | Exam of visual field with limited testing | Office | 2023 | 18 | 20 | $1,300 | $232.56 | 17.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 102 | 151 | $22,952 | $4,032 | 17.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2022 | 75 | 119 | $18,088 | $3,425 | 18.9% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 72 | 77 | $10,395 | $3,023 | 29.1% |
| 92012 | Established patient problem focused exam of visual system | Facility | 2022 | 68 | 73 | $9,920 | $2,745 | 27.7% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 43 | 45 | $9,495 | $2,233 | 23.5% |
| 68801 | Dilation of tear drainage opening | Office | 2022 | 16 | 18 | $10,440 | $1,425 | 13.7% |
| 92002 | New patient problem focused exam of visual system | Office | 2022 | 34 | 34 | $5,746 | $1,266 | 22.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 22 | 22 | $7,634 | $1,118 | 14.6% |
| 92014 | Established patient complete exam of visual system | Facility | 2022 | 18 | 19 | $4,009 | $850.35 | 21.2% |
| 92081 | Exam of visual field with limited testing | Facility | 2022 | 17 | 25 | $1,625 | $288.28 | 17.7% |
| 92081 | Exam of visual field with limited testing | Office | 2022 | 22 | 24 | $1,560 | $273.53 | 17.5% |
| 92285 | Photography of content of eyes | Facility | 2022 | 11 | 11 | $121.00 | $27.41 | 22.7% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 142 | 231 | $35,112 | $6,544 | 18.6% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Facility | 2021 | 81 | 116 | $17,632 | $3,414 | 19.4% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 50 | 51 | $10,761 | $2,707 | 25.2% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 54 | 58 | $7,830 | $2,212 | 28.2% |
About Dr. David Yoo, MD
Dr. David Yoo, MD is a Ophthalmic Plastic and Reconstructive Surgery healthcare provider based in Aurora, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1548343155.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Yoo, MD has received a total of $9,892 in payments from pharmaceutical and medical device companies, with $262.45 received in 2024. These payments were reported across 20 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($7,140).
As a Medicare-enrolled provider, Yoo has provided services to 1,958 Medicare beneficiaries, totaling 2,442 services with total Medicare billing of $86,264. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmic Plastic and Reconstructive Surgery
- Other Specialties Ophthalmology
- Location Aurora, IL
- Active Since 10/24/2006
- Last Updated 03/04/2024
- Taxonomy Code 207WX0200X
- Entity Type Individual
- NPI Number 1548343155
Products in Payments
- EYLEA HD (Biological) $7,140
- Erivedge (Biological) $131.75
- XDEMVY (Drug) $121.49
- TEPEZZA (Biological) $95.77
- OZURDEX (Drug) $25.92
- DUPIXENT (Biological) $25.22
- VYZULTA (Drug) $19.27
- DAILIES (Device) $15.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmic Plastic and Reconstructive Surgery Doctors in Aurora
Katherine Lucarelli, Md, MD
Ophthalmic Plastic and Reconstructive Surgery — Payments: $1,018
Ophthalmic Plastic and Reconstructive Surgery $1,018
Dr. Sophie Liao, M.d, M.D
Ophthalmic Plastic and Reconstructive Surgery — Payments: $590.90
Ophthalmic Plastic and Reconstructive Surgery $590.90
Amy Huang, Md, MD
Ophthalmic Plastic and Reconstructive Surgery — Payments: $442.69
Ophthalmic Plastic and Reconstructive Surgery $442.69